• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥尔波特肾小球病变起始与进展的分子和细胞机制

Molecular and Cellular Mechanisms Underlying the Initiation and Progression of Alport Glomerular Pathology.

作者信息

Cosgrove Dominic, Madison Jacob

机构信息

Boys Town National Research Hospital, Omaha, NE, United States.

出版信息

Front Med (Lausanne). 2022 Feb 9;9:846152. doi: 10.3389/fmed.2022.846152. eCollection 2022.

DOI:10.3389/fmed.2022.846152
PMID:35223933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8863674/
Abstract

Alport syndrome results from a myriad of variants in the COL4A3, COL4A4, or COL4A5 genes that encode type IV (basement membrane) collagens. Unlike type IV collagen α1(IV)α2(IV) heterotrimers, which are ubiquitous in basement membranes, α3/α4/α5 have a limited tissue distribution. The absence of these basement membrane networks causes pathologies in some, but not all these tissues. Primarily the kidney glomerulus, the stria vascularis of the inner ear, the lens, and the retina as well as a rare link with aortic aneurisms. Defects in the glomerular basement membranes results in delayed onset and progressive focal segmental glomerulosclerosis ultimately requiring the patient to undergo dialysis and if accessible, kidney transplant. The lifespan of patients with Alport syndrome is ultimately significantly shortened. This review addresses the consequences of the altered glomerular basement membrane composition in Alport syndrome with specific emphasis on the mechanisms underlying initiation and progression of glomerular pathology.

摘要

奥尔波特综合征由编码IV型(基底膜)胶原蛋白的COL4A3、COL4A4或COL4A5基因中的多种变异引起。与在基底膜中普遍存在的IV型胶原蛋白α1(IV)α2(IV)异源三聚体不同,α3/α4/α5的组织分布有限。这些基底膜网络的缺失会在部分而非所有这些组织中引发病变。主要累及肾小球、内耳的血管纹、晶状体、视网膜,以及与主动脉瘤的罕见关联。肾小球基底膜的缺陷会导致发病延迟和进行性局灶节段性肾小球硬化,最终患者需要接受透析治疗,若有合适的肾脏,还需进行肾移植。奥尔波特综合征患者的寿命最终会显著缩短。本综述探讨了奥尔波特综合征中肾小球基底膜成分改变的后果,特别强调了肾小球病变起始和进展的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4734/8863674/c1ab9fc1afd8/fmed-09-846152-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4734/8863674/e06ff2c3bb7c/fmed-09-846152-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4734/8863674/c1ab9fc1afd8/fmed-09-846152-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4734/8863674/e06ff2c3bb7c/fmed-09-846152-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4734/8863674/c1ab9fc1afd8/fmed-09-846152-g0002.jpg

相似文献

1
Molecular and Cellular Mechanisms Underlying the Initiation and Progression of Alport Glomerular Pathology.奥尔波特肾小球病变起始与进展的分子和细胞机制
Front Med (Lausanne). 2022 Feb 9;9:846152. doi: 10.3389/fmed.2022.846152. eCollection 2022.
2
Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys.正常及X连锁遗传性肾炎肾脏中IV型胶原链的肾小球表达
Am J Pathol. 2000 Jun;156(6):1901-10. doi: 10.1016/S0002-9440(10)65063-8.
3
Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.IV型胶原疾病:聚焦于Alport综合征中的肾小球基底膜。
Matrix Biol. 2017 Jan;57-58:45-54. doi: 10.1016/j.matbio.2016.08.005. Epub 2016 Aug 27.
4
Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice.整合素 α1 在系膜细胞中的表达上调,整合素 α3 和波形蛋白在 Col4a3 缺失(Alport)小鼠的足细胞中表达。
PLoS One. 2012;7(12):e50745. doi: 10.1371/journal.pone.0050745. Epub 2012 Dec 7.
5
Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.肾小球基底膜中α3/α4(IV)型胶原蛋白的缺失会诱导一种应变依赖性的异构体转换为α5α6(IV)型胶原蛋白,这与Col4a3-/- Alport小鼠更长的肾脏存活时间相关。
J Am Soc Nephrol. 2006 Jul;17(7):1962-9. doi: 10.1681/ASN.2006020165. Epub 2006 Jun 12.
6
Alport Syndrome: Clinical Spectrum and Therapeutic Advances.奥尔波特综合征:临床谱与治疗进展
Kidney Med. 2023 Mar 21;5(5):100631. doi: 10.1016/j.xkme.2023.100631. eCollection 2023 May.
7
Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease.骨髓源性干细胞修复基底膜胶原蛋白缺陷并逆转遗传性肾病。
Proc Natl Acad Sci U S A. 2006 May 9;103(19):7321-6. doi: 10.1073/pnas.0601436103. Epub 2006 Apr 28.
8
[Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].[奥尔波特综合征:与IV型胶原链编码基因突变相关的遗传性肾病]
Nephrol Ther. 2016 Dec;12(7):544-551. doi: 10.1016/j.nephro.2016.09.001. Epub 2016 Nov 2.
9
Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome.肾小球基底膜蛋白表达与常染色体显性遗传性阿尔波特综合征的诊断及预后
Kidney Med. 2019 Aug 20;1(6):391-396. doi: 10.1016/j.xkme.2019.06.007. eCollection 2019 Nov-Dec.
10
Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review.致病变异在 Alport 综合征(COL4A3-COL4A5)相关基因中的作用及其与其他肾脏疾病的关系:综述。
Am J Kidney Dis. 2021 Dec;78(6):857-864. doi: 10.1053/j.ajkd.2021.04.017. Epub 2021 Jul 8.

引用本文的文献

1
The role of endothelin receptor antagonists in kidney disease.内皮素受体拮抗剂在肾脏疾病中的作用。
Ren Fail. 2025 Dec;47(1):2465810. doi: 10.1080/0886022X.2025.2465810. Epub 2025 Feb 27.
2
Genotype-Based Molecular Mechanisms in Alport Syndrome.阿尔波特综合征基于基因型的分子机制
J Am Soc Nephrol. 2025 Jun 1;36(6):1176-1183. doi: 10.1681/ASN.0000000647. Epub 2025 Feb 3.
3
Rescue of mitochondrial dysfunction through alteration of extracellular matrix composition in barth syndrome cardiac fibroblasts.通过改变巴氏综合征心脏成纤维细胞的细胞外基质组成来挽救线粒体功能障碍

本文引用的文献

1
Intravital imaging reveals glomerular capillary distension and endothelial and immune cell activation early in Alport syndrome.活体成像技术揭示了 Alport 综合征早期肾小球毛细血管扩张以及内皮细胞和免疫细胞的激活。
JCI Insight. 2022 Jan 11;7(1):e152676. doi: 10.1172/jci.insight.152676.
2
Effect of disease progression on the podocyte cell cycle in Alport Syndrome.Alport 综合征中疾病进展对足细胞细胞周期的影响。
Kidney Int. 2022 Jan;101(1):106-118. doi: 10.1016/j.kint.2021.08.026. Epub 2021 Sep 23.
3
Prevalence Estimates of Predicted Pathogenic Variants in a Population Sequencing Database and Their Implications for Alport Syndrome.
Biomaterials. 2025 Apr;315:122922. doi: 10.1016/j.biomaterials.2024.122922. Epub 2024 Oct 26.
4
A Randomized Controlled Clinical Trial Testing Effects of Lademirsen on Kidney Function Decline in Adults with Alport Syndrome.一项随机对照临床试验,旨在测试 Lademirsen 对 Alport 综合征成人肾功能下降的影响。
Clin J Am Soc Nephrol. 2024 Aug 1;19(8):995-1004. doi: 10.2215/CJN.0000000000000458. Epub 2024 Jun 3.
5
A Novel Pathogenic Variant Joins the Dots in a Family with a Synchronous Diagnosis of Alport Syndrome and Polycystic Kidney Disease.一种新的致病性变异在一个同时诊断出 Alport 综合征和多囊肾病的家族中串联起了各个点。
Genes (Basel). 2024 May 8;15(5):597. doi: 10.3390/genes15050597.
6
Structural modification of C2-substituents on 1,4-bis(arylsulfonamido)benzene or naphthalene-N,N'-diacetic acid derivatives as potent inhibitors of the Keap1-Nrf2 protein-protein interaction.对 1,4-双(芳磺酰胺基)苯或萘- N,N'-二乙酸衍生物的 C2-取代基进行结构修饰,得到有效的 Keap1-Nrf2 蛋白-蛋白相互作用抑制剂。
Eur J Med Chem. 2024 Feb 5;265:116104. doi: 10.1016/j.ejmech.2023.116104. Epub 2023 Dec 27.
7
Proteomic Analysis on Sequential Samples of Cystic Fluid Obtained from Human Brain Tumors.人脑肿瘤囊性液体连续样本的蛋白质组学分析
Cancers (Basel). 2023 Aug 11;15(16):4070. doi: 10.3390/cancers15164070.
8
Potential Renal Damage Biomarkers in Alport Syndrome-A Review of the Literature.Alport 综合征潜在的肾损伤生物标志物研究进展。
Int J Mol Sci. 2022 Jun 30;23(13):7276. doi: 10.3390/ijms23137276.
人群测序数据库中预测致病性变异的流行率估计及其对 Alport 综合征的影响。
J Am Soc Nephrol. 2021 Sep;32(9):2273-2290. doi: 10.1681/ASN.2020071065. Epub 2021 Jun 18.
4
Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Hereditary Podocytopathies, Alport Syndrome, and FSGS: A Case Series to Better Plan a Large-Scale Study.钠-葡萄糖共转运蛋白 2 抑制剂在遗传性足细胞病、Alport 综合征和 FSGS 患者中的应用:一项病例系列研究以更好地规划大规模研究。
Cells. 2021 Jul 18;10(7):1815. doi: 10.3390/cells10071815.
5
Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease.靶向 OSBPL7 的化合物可增加 ABCA1 依赖性胆固醇流出,从而在两种肾病模型中维持肾功能。
Nat Commun. 2021 Aug 2;12(1):4662. doi: 10.1038/s41467-021-24890-3.
6
Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review.致病变异在 Alport 综合征(COL4A3-COL4A5)相关基因中的作用及其与其他肾脏疾病的关系:综述。
Am J Kidney Dis. 2021 Dec;78(6):857-864. doi: 10.1053/j.ajkd.2021.04.017. Epub 2021 Jul 8.
7
Identification of an Altered Matrix Signature in Kidney Aging and Disease.肾脏衰老和疾病中改变的基质特征的鉴定。
J Am Soc Nephrol. 2021 Jul;32(7):1713-1732. doi: 10.1681/ASN.2020101442. Epub 2021 May 28.
8
Metformin ameliorates the severity of experimental Alport syndrome.二甲双胍可改善实验性 Alport 综合征的严重程度。
Sci Rep. 2021 Mar 29;11(1):7053. doi: 10.1038/s41598-021-86109-1.
9
HMGB-1 and TGFβ-1 highlight immuno-inflammatory and fibrotic processes before proteinuria onset in pediatric patients with Alport syndrome.HMGB-1 和 TGFβ-1 在小儿 Alport 综合征患者出现蛋白尿前就提示免疫炎症和纤维化过程。
J Nephrol. 2021 Dec;34(6):1915-1924. doi: 10.1007/s40620-021-01015-z. Epub 2021 Mar 24.
10
Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome.Discoidin domain receptor 1 激活将细胞外基质与 Alport 综合征中足细胞的脂毒性联系起来。
EBioMedicine. 2021 Jan;63:103162. doi: 10.1016/j.ebiom.2020.103162. Epub 2020 Dec 16.